Zimin Sun
About
Zimin Sun is a scholar working on Hematology, Oncology and Immunology.
According to data from OpenAlex, Zimin Sun has authored 98 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hematology, 29 papers in Oncology and 25 papers in Immunology. Recurrent topics in Zimin Sun's work include Hematopoietic Stem Cell Transplantation (52 papers), Acute Myeloid Leukemia Research (29 papers) and Immune Cell Function and Interaction (19 papers). Zimin Sun is often cited by papers focused on Hematopoietic Stem Cell Transplantation (52 papers), Acute Myeloid Leukemia Research (29 papers) and Immune Cell Function and Interaction (19 papers). Zimin Sun collaborates with scholars based in China, United States and Australia. Zimin Sun's co-authors include Huilan Liu, Baolin Tang, Xiaoyu Zhu, Liangquan Geng, Changcheng Zheng, Xiao‐Jun Huang, Lan‐Ping Xu, Jing Chen, Qifa Liu and Yongping Song and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Zimin Sun
85 papers receiving 1.3k citations
Hit Papers
Peers
Zimin Sun
Asahito Hama Japan
Mouhab Ayas Saudi Arabia
Nobuhiro Nishio Japan
Tohru Inaba Japan
Brigitte Strahm Germany
Hiroaki Goto Japan
Sujith Samarasinghe United Kingdom
Yukiyasu Ozawa Japan
Miharu Yabe Japan
Valentina Giudice Italy
Citations per year, relative to Zimin Sun Zimin Sun (= 1×)
peers
Asahito Hama
Countries citing papers authored by Zimin Sun
Since
Specialization
Citations
This map shows the geographic impact of Zimin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zimin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zimin Sun more than expected).
Fields of papers citing papers by Zimin Sun
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Zimin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zimin Sun. The network helps show where Zimin Sun may publish in the future.
Co-authorship network of co-authors of Zimin Sun
This figure shows the co-authorship network connecting the top 25 collaborators of Zimin Sun. A scholar is included among the top collaborators of Zimin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zimin Sun. Zimin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Wang, Li, Na Zhao, Li Zhou, et al.. (2022). Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study. SHILAP Revista de lepidopterología.
2.
Wang, Huiru, Huilan Liu, Zhou Li, et al.. (2022). Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation. iScience. 25(10). 105065–105065.
3.
Qin, Xia, Yiping Zhu, Ming Zhou, et al.. (2021). Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6–7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years. Annals of Hematology. 100(9). 2363–2373.
4.
Sun, Guangyu, Baolin Tang, Mei‐Juan Tu, et al.. (2021). Chimeric Antigen Receptor T Cell Therapy followed by Unrelated Cord Blood Transplantation for the Treatment of Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia in Children and Young Adults: Superior Survival but Relatively High Post-Transplantation Relapse. Transplantation and Cellular Therapy. 28(2). 71.e1–71.e8.
5.
Sun, Zimin, Huilan Liu, Xiaoyu Zhu, et al.. (2021). Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients. Nature Communications. 12(1). 4137–4137.
6.
Zhu, Xiaoyu, Baolin Tang, Liangquan Geng, et al.. (2020). Decitabine prior to salvaged cord blood transplantation for acute myeloid leukaemia/myelodysplastic syndrome not in remission. Journal of Clinical Pharmacy and Therapeutics. 45(6). 1372–1381.
7.
Zhou, Li, Guangyu Sun, Baolin Tang, et al.. (2019). <p>Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease</p>. Infection and Drug Resistance. Volume 12. 481–491.
8.
Chen, Yao, Weijun Fu, Lan‐Ping Xu, et al.. (2019). Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myeloma. Chinese Medical Journal. 132(15). 1765–1772.
9.
Xu, Lan‐Ping, Chen Hu, Jing Chen, et al.. (2018). The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology. Journal of Hematology & Oncology. 11(1). 33–33.
10.
Zhu, Xiaoyu, Lulu Huang, Changcheng Zheng, et al.. (2017). European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 23(12). 2118–2126.
11.
Zhu, Xiaoyu, Xin Liu, Zhongyi Cheng, et al.. (2016). Quantitative Analysis of Global Proteome and Lysine Acetylome Reveal the Differential Impacts of VPA and SAHA on HL60 Cells. Scientific Reports. 6(1). 19926–19926.
12.
Sun, Zimin, Li Zhou, Xin Liu, et al.. (2016). A comparative study of idarubicin 12 mg/m2 and 8 mg/m2 combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients. OncoTargets and Therapy. 9. 985–985.
13.
Zhou, Li, Xin Liu, Xingbing Wang, Zimin Sun, & Xiao‐Tong Song. (2015). CD123 redirected multiple virus-specific T cells for acute myeloid leukemia. Leukemia Research. 41. 76–84.
14.
Zheng, Changcheng, Xiaoyu Zhu, Baolin Tang, et al.. (2015). The impact of pre-transplant minimal residual disease on outcome of intensified myeloablative cord blood transplant for acute myeloid leukemia in first or second complete remission. Leukemia & lymphoma. 57(6). 1398–1405.
15.
Zheng, Changcheng, Zuo Luan, Jian‐Pei Fang, et al.. (2015). Comparison of Conditioning Regimens with or without Antithymocyte Globulin for Unrelated Cord Blood Transplantation in Children with High-Risk or Advanced Hematological Malignancies. Biology of Blood and Marrow Transplantation. 21(4). 707–712.
16.
Wang, Anyou, et al.. (2015). The expression of ADAMTS13 in human microvascular endothelial cells. Blood Coagulation & Fibrinolysis. 27(4). 464–466.
17.
Zheng, Changcheng, Xiaoyu Zhu, Baolin Tang, et al.. (2014). Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia. Annals of Hematology. 94(3). 473–480.
18.
Li, Qing, Xiucai Xu, Yuanyuan Shen, et al.. (2010). Decrease of CD4+CD25+ regulatory T cells and TGF-β at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation. Leukemia Research. 34(9). 1158–1168.
19.
Wang, Xingbing, Yuling He, Feng Yu, et al.. (2007). CCL19 and CXCL13 Synergistically Regulate Interaction between B Cell Acute Lymphocytic Leukemia CD23+CD5+ B Cells and CD8+ T Cells. The Journal of Immunology. 179(5). 2880–2888.
20.
Liu, Jian, Jintian Yang, Ren An, et al.. (2005). Increased serum cathepsin S in patients with atherosclerosis and diabetes. Atherosclerosis. 186(2). 411–419.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Asahito Hama Breakdown of academic impact, for papers by Mouhab Ayas Breakdown of academic impact, for papers by Nobuhiro Nishio Breakdown of academic impact, for papers by Tohru Inaba Breakdown of academic impact, for papers by Brigitte Strahm Breakdown of academic impact, for papers by Hiroaki Goto Breakdown of academic impact, for papers by Sujith Samarasinghe Breakdown of academic impact, for papers by Yukiyasu Ozawa Breakdown of academic impact, for papers by Miharu Yabe Breakdown of academic impact, for papers by Valentina Giudice